US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Nov. 3 for "Chemically reversible 2'-OH acylation protects RNA from hydrolytic and enzymatic degradation" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,220, issued on Nov. 3, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.). "Chemically revers... Read More

US Patent Issued to TORAY INDUSTRIES on Nov. 3 for "Nucleic acid construct" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,221, issued on Nov. 3, was assigned to TORAY INDUSTRIES Inc. (Tokyo). "Nucleic acid construct" was invented by Atsuki Tsuruya (Kamakura, Jap... Read More

US Patent Issued to Ionis Pharmaceuticals on Nov. 3 for "Oligomer-conjugate complexes and their use" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,222, issued on Nov. 3, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.). "Oligomer-conjugate complexes and their use" was inven... Read More

US Patent Issued to uniQure IP on Nov. 3 for "RNAi induced Huntingtin gene suppression" (Dutch Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,223, issued on Nov. 3, was assigned to uniQure IP B.V. (Amsterdam). "RNAi induced Huntingtin gene suppression" was invented by Pavlina Stefa... Read More

US Patent Issued to ELI LILLY and Co. on Nov. 3 for "MAPT RNA interference agents" (American, German Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,224, issued on Nov. 3, was assigned to ELI LILLY AND COMPANY (Indianapolis). "MAPT RNA interference agents" was invented by Barbara Calamini... Read More

US Patent Issued to Souffle Therapeutics on Nov. 3 for "Oligonucleotide-mediated knockdown of DUX4" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,225, issued on Nov. 3, was assigned to Souffle Therapeutics Inc. (Watertown, Mass.). "Oligonucleotide-mediated knockdown of DUX4" was invent... Read More

US Patent Issued to Wyvern Pharmaceuticals on Nov. 3 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,226, issued on Nov. 3, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada). "Composition for regulating production of interfering ... Read More

US Patent Issued to Seattle Children's Hospital on Nov. 3 for "Talen-based and CRISPR/Cas-based gene editing for Bruton's tyrosine kinase" (Washington Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,227, issued on Nov. 3, was assigned to Seattle Children's Hospital (Seattle). "Talen-based and CRISPR/Cas-based gene editing for Bruton's ty... Read More

US Patent Issued to Alnylam Pharmaceuticals on Nov. 3 for "Angiotensin-converting enzyme 2 (ACE2) iRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,228, issued on Nov. 3, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.). "Angiotensin-converting enzyme 2 (ACE2) iRNA composi... Read More

US Patent Issued to KUMIAI CHEMICAL INDUSTRY, UNIVERSITY PUBLIC CORPORATION OSAKA on Nov. 3 for "Nucleic acid that interacts with a receptor for endocrine disrupting chemicals and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,229, issued on Nov. 3, was assigned to KUMIAI CHEMICAL INDUSTRY Co. LTD. (Tokyo) and UNIVERSITY PUBLIC CORPORATION OSAKA (Osaka, Japan). "Nu... Read More

• ««
• «
• 3294
• 3295
• 3296
• 3297
• 3298
• 3299
• 3300
• 3301
• 3302
• 3303
• »
• »»